首页 > 最新文献

The Lancet Regional Health: Western Pacific最新文献

英文 中文
Chikungunya: a growing public health concern in the Western Pacific region 基孔肯雅热:西太平洋区域日益严重的公共卫生问题
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101733
The Lancet Regional Health – Western Pacific
{"title":"Chikungunya: a growing public health concern in the Western Pacific region","authors":"The Lancet Regional Health – Western Pacific","doi":"10.1016/j.lanwpc.2025.101733","DOIUrl":"10.1016/j.lanwpc.2025.101733","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101733"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145417068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving support for people with mental health problems in China: a cluster randomised controlled trial of culturally adapted Mental Health First Aid training 改善对中国精神健康问题患者的支持:一项文化适应精神健康急救培训的随机对照试验
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101698
Nicola Reavley , Amy J. Morgan , Anthony F. Jorm , Betty Kitchener , Yan Wang , Shurong Lu , Wenjing Li , Claire Kelly , Brian Oldenburg , Min Zhao , Yanling He

Background

Culturally appropriate interventions that teach members of the public to provide early help towards a person developing a mental health problem or in a mental health crisis may improve access to services, social support, and mental health outcomes. This is the first study to evaluate the effectiveness of culturally adapted Mental Health First Aid (MHFA) Training for China.

Methods

A two-arm wait-list pilot cluster randomised controlled trial (cRCT) was conducted in 3 settings in Shanghai (health services, workplaces and community settings). Intervention settings were paired according to type and one of each pair was randomly allocated to the intervention (MHFA Training for China) or the wait-list control group, with a 1:1 allocation. Participants were invited by the trial coordinators in each setting. They were asked to complete questionnaires at baseline (T1) and 1 month (T2) and 7 months after training (T3). Control group participants were asked to complete questionnaires at corresponding times. The primary outcome was participant intended actions (recommended or not recommended) towards a person experiencing a mental health problem or in a mental health crisis. Secondary outcomes included recognition of depression in a vignette; beliefs about the helpfulness of health professionals and interventions; helping actions; confidence in providing mental health first aid; and stigmatising attitudes.

Findings

Between April and May 2024, 6 clusters were recruited and randomised, with 3 in each of the intervention and control arms. Following exclusion of participants who did not provide data, 146 participants were included at baseline: 67 in the intervention group and 79 in the control group. For the primary outcome (recommended actions subscale), the intervention group showed a significantly larger improvement than the control group at T2 (8.19 [95% CI 4.05–12.34]; p < 0.001) and T3 (3.08 [95% CI −1.02 to 7.18]; p = 0.034). Differences in changes in non-recommended actions were non-significant. At T2, significant differences favouring the intervention group were observed in confidence to provide support, perceiving the person as dangerous or unpredictable and in recognition of depression in a vignette. There were no significant differences in secondary outcomes at T3.

Interpretation

Delivering culturally adapted MHFA Training for China more widely could improve support for people experiencing mental health problems in the community.

Funding

This trial was supported the National Health and Medical Research Council under a Global Alliance for Chronic Diseases grant (GNT1142395).
背景:在文化上适当的干预措施,教导公众对出现精神健康问题或处于精神健康危机中的人提供早期帮助,可能会改善获得服务、社会支持和精神健康结果的机会。这是第一个评估中国文化适应性心理健康急救(MHFA)培训有效性的研究。方法在上海市卫生服务机构、工作场所和社区3个环境中进行两臂等待名单试验随机对照试验(cRCT)。将干预设置按类型进行配对,每对中随机分配1个干预组(MHFA中国培训组)或等候名单对照组,按1:1的比例分配。参与者是由试验协调员在每种情况下邀请的。在基线(T1)、训练后1个月(T2)和7个月(T3)完成问卷调查。对照组参与者被要求在相应的时间完成问卷调查。主要结果是参与者对经历精神健康问题或处于精神健康危机的人有意采取的行动(建议或不建议)。次要结局包括在小插曲中识别抑郁症;对卫生专业人员的帮助和干预措施的信念;帮助行为;对提供精神卫生急救的信心;以及污名化的态度。在2024年4月至5月期间,招募并随机分组了6组,干预组和对照组各3组。在排除了没有提供数据的参与者后,146名参与者在基线时被纳入:干预组67名,对照组79名。对于主要结局(推荐行动分量表),干预组在T2 (8.19 [95% CI 4.05-12.34]; p < 0.001)和T3 (3.08 [95% CI - 1.02至7.18];p = 0.034)时的改善显著大于对照组。非推荐行动的变化差异不显著。在T2时,观察到干预组在提供支持的信心,感知该人危险或不可预测以及在小插曲中识别抑郁症方面存在显著差异。T3时的次要结局无显著差异。在中国更广泛地开展与文化相适应的MHFA培训可以改善对社区中遇到精神健康问题的人的支持。该试验由国家卫生和医学研究委员会在全球慢性疾病联盟资助下(GNT1142395)支持。
{"title":"Improving support for people with mental health problems in China: a cluster randomised controlled trial of culturally adapted Mental Health First Aid training","authors":"Nicola Reavley ,&nbsp;Amy J. Morgan ,&nbsp;Anthony F. Jorm ,&nbsp;Betty Kitchener ,&nbsp;Yan Wang ,&nbsp;Shurong Lu ,&nbsp;Wenjing Li ,&nbsp;Claire Kelly ,&nbsp;Brian Oldenburg ,&nbsp;Min Zhao ,&nbsp;Yanling He","doi":"10.1016/j.lanwpc.2025.101698","DOIUrl":"10.1016/j.lanwpc.2025.101698","url":null,"abstract":"<div><h3>Background</h3><div>Culturally appropriate interventions that teach members of the public to provide early help towards a person developing a mental health problem or in a mental health crisis may improve access to services, social support, and mental health outcomes. This is the first study to evaluate the effectiveness of culturally adapted Mental Health First Aid (MHFA) Training for China.</div></div><div><h3>Methods</h3><div>A two-arm wait-list pilot cluster randomised controlled trial (cRCT) was conducted in 3 settings in Shanghai (health services, workplaces and community settings). Intervention settings were paired according to type and one of each pair was randomly allocated to the intervention (MHFA Training for China) or the wait-list control group, with a 1:1 allocation. Participants were invited by the trial coordinators in each setting. They were asked to complete questionnaires at baseline (T1) and 1 month (T2) and 7 months after training (T3). Control group participants were asked to complete questionnaires at corresponding times. The primary outcome was participant intended actions (recommended or not recommended) towards a person experiencing a mental health problem or in a mental health crisis. Secondary outcomes included recognition of depression in a vignette; beliefs about the helpfulness of health professionals and interventions; helping actions; confidence in providing mental health first aid; and stigmatising attitudes.</div></div><div><h3>Findings</h3><div>Between April and May 2024, 6 clusters were recruited and randomised, with 3 in each of the intervention and control arms. Following exclusion of participants who did not provide data, 146 participants were included at baseline: 67 in the intervention group and 79 in the control group. For the primary outcome (recommended actions subscale), the intervention group showed a significantly larger improvement than the control group at T2 (8.19 [95% CI 4.05–12.34]; p &lt; 0.001) and T3 (3.08 [95% CI −1.02 to 7.18]; p = 0.034). Differences in changes in non-recommended actions were non-significant. At T2, significant differences favouring the intervention group were observed in confidence to provide support, perceiving the person as dangerous or unpredictable and in recognition of depression in a vignette. There were no significant differences in secondary outcomes at T3.</div></div><div><h3>Interpretation</h3><div>Delivering culturally adapted MHFA Training for China more widely could improve support for people experiencing mental health problems in the community.</div></div><div><h3>Funding</h3><div>This trial was supported the <span>National Health and Medical Research Council</span> under a <span>Global Alliance for Chronic Diseases</span> grant (<span><span>GNT1142395</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101698"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145222340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community-based versus facility-based services to improve hepatitis C screening in Cambodia: a cluster randomized controlled trial (ANRS 12384 Cam-C study) 以社区为基础的服务与以设施为基础的服务改善柬埔寨丙型肝炎筛查:一项随机对照试验(ANRS 12384 Cam-C研究)
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101703
Dyna Khuon , Luis Sagaon-Teyssier , Sansothy Neth , Saly Saint , Laurence Meyer , Emilie Mosnier , Diana Molino , Chan Leakhena Phoeung , Chhingsrean Chhay , Kimeang Heang , Sovatha Mam , Jean-Charles Duclos-Vallée , Olivier Ségéral , Vonthanak Saphonn

Background

The estimated prevalence of hepatitis C virus (HCV) infection among adults aged over 45 years in Cambodia is approximately 5%. The present study aimed assessing the effectiveness of a novel community-based strategy comprising HCV rapid testing (RDT) and dried blood spot (DBS) collection performed by community health workers (CHWs) in outreach contexts.

Methods

ANRS 12384 Cam-C is a parallel arm cluster randomized controlled trial conducted in the Siem Reap and Kampong Cham provinces of Cambodia between April 2022 and September 2023. Four geographical areas in each province were randomized into two arms to compare HCV RDT and DBS collection provided in homes by community health workers (i.e., community-based strategy) with facility-based HCV RDT and whole blood collection provided by healthcare workers in health centers (i.e., facility-based strategy). The primary outcome was combined testing uptake, defined as the proportion of participants who were actually tested for HCV using RDT or RDT/RNA if positive out of all those who participated in the study. Mixed effects logistic models were used to estimate the effect of the community-based strategy. The study is registered on ClinicalTrials.gov (NCT03992313).

Findings

Among the 7692 participants who initially enrolled in the study, 5590 (72.7%) actually went on to have HCV RDT or HCV RDT/RNA screening (i.e., combined testing uptake). Combined testing uptake in the community-based (2990 participants) and facility-based (2600 participants) arms was 78.1% and 67.3%, respectively (p < 0.001). Positive HCV RDT was found for 57 (2.2%) including 39 (1.5%) with detectable HCV RNA among participants in the facility-based arm. In the community-based arm, 37 (1.2%) had positive HCV RDT including 32 (1.1%) with detectable HCV RNA. Treatment uptake concerned 36 participants (out of 39 with positive HCV RDT) and 30 (out of 32) in the facility-based and community-based arms, respectively. The odds of combined testing uptake in the community-based strategy were 2.18 (95% CI [1.28–3.73], p = 0.004) times higher than in the facility-based strategy.

Interpretation

Combined testing uptake (HCV RDT or HCV RDT/RNA) was higher for the community-based strategy than for the facility-based strategy. The involvement of community health workers improved first contact with HCV services and uptake. Integrating this trial's community-based screening strategy into the national Cambodian HCV program could improve its effectiveness as part of the country's broader goal of eliminating HCV by 2030.

Funding

This study was supported by the ANRS MIE (ANRS 12384).
柬埔寨45岁以上成年人中丙型肝炎病毒(HCV)感染的估计流行率约为5%。本研究旨在评估一种新型社区策略的有效性,该策略包括由社区卫生工作者(CHWs)在外展环境中执行的HCV快速检测(RDT)和干血斑(DBS)收集。方法sanrs 12384 Cam-C是一项平行臂群随机对照试验,于2022年4月至2023年9月在柬埔寨暹粒省和磅湛省进行。每个省的四个地理区域被随机分为两组,以比较社区卫生工作者在家中提供的HCV RDT和DBS采集(即基于社区的策略)与卫生中心卫生工作者提供的基于设施的HCV RDT和全血采集(即基于设施的策略)。主要结果是综合检测摄取,定义为在所有参与研究的参与者中,使用RDT或RDT/RNA进行HCV检测的参与者比例(如果RDT/RNA阳性)。混合效应logistic模型用于评估社区策略的效果。该研究已在ClinicalTrials.gov注册(NCT03992313)。在7692名最初参加研究的参与者中,5590名(72.7%)实际上继续进行了HCV RDT或HCV RDT/RNA筛查(即联合检测摄取)。以社区为基础(2990名参与者)和以医疗机构为基础(2600名参与者)两组的联合测试接受率分别为78.1%和67.3% (p < 0.001)。HCV RDT阳性57人(2.2%),其中39人(1.5%)HCV RNA可检测。在社区组中,37例(1.2%)HCV RDT阳性,其中32例(1.1%)HCV RNA可检测。治疗接受情况分别涉及36名参与者(39名HCV RDT阳性)和30名参与者(32名),分别来自设施组和社区组。以社区为基础的策略采用联合检测的几率是以设施为基础策略的2.18倍(95% CI [1.28-3.73], p = 0.004)。以社区为基础的策略比以设施为基础的策略的综合检测摄取(HCV RDT或HCV RDT/RNA)更高。社区卫生工作者的参与改善了初次接触丙型肝炎病毒的服务和吸收情况。将该试验的基于社区的筛查策略纳入柬埔寨全国丙肝病毒规划,可以提高其有效性,使其成为该国到2030年消除丙肝病毒这一更广泛目标的一部分。本研究由ANRS MIE (ANRS 12384)支持。
{"title":"Community-based versus facility-based services to improve hepatitis C screening in Cambodia: a cluster randomized controlled trial (ANRS 12384 Cam-C study)","authors":"Dyna Khuon ,&nbsp;Luis Sagaon-Teyssier ,&nbsp;Sansothy Neth ,&nbsp;Saly Saint ,&nbsp;Laurence Meyer ,&nbsp;Emilie Mosnier ,&nbsp;Diana Molino ,&nbsp;Chan Leakhena Phoeung ,&nbsp;Chhingsrean Chhay ,&nbsp;Kimeang Heang ,&nbsp;Sovatha Mam ,&nbsp;Jean-Charles Duclos-Vallée ,&nbsp;Olivier Ségéral ,&nbsp;Vonthanak Saphonn","doi":"10.1016/j.lanwpc.2025.101703","DOIUrl":"10.1016/j.lanwpc.2025.101703","url":null,"abstract":"<div><h3>Background</h3><div>The estimated prevalence of hepatitis C virus (HCV) infection among adults aged over 45 years in Cambodia is approximately 5%. The present study aimed assessing the effectiveness of a novel community-based strategy comprising HCV rapid testing (RDT) and dried blood spot (DBS) collection performed by community health workers (CHWs) in outreach contexts.</div></div><div><h3>Methods</h3><div>ANRS 12384 Cam-C is a parallel arm cluster randomized controlled trial conducted in the Siem Reap and Kampong Cham provinces of Cambodia between April 2022 and September 2023. Four geographical areas in each province were randomized into two arms to compare HCV RDT and DBS collection provided in homes by community health workers (i.e., community-based strategy) with facility-based HCV RDT and whole blood collection provided by healthcare workers in health centers (i.e., facility-based strategy). The primary outcome was combined testing uptake, defined as the proportion of participants who were actually tested for HCV using RDT or RDT/RNA if positive out of all those who participated in the study. Mixed effects logistic models were used to estimate the effect of the community-based strategy. The study is registered on <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (<span><span>NCT03992313</span><svg><path></path></svg></span>).</div></div><div><h3>Findings</h3><div>Among the 7692 participants who initially enrolled in the study, 5590 (72.7%) actually went on to have HCV RDT or HCV RDT/RNA screening (i.e., combined testing uptake). Combined testing uptake in the community-based (2990 participants) and facility-based (2600 participants) arms was 78.1% and 67.3%, respectively (p &lt; 0.001). Positive HCV RDT was found for 57 (2.2%) including 39 (1.5%) with detectable HCV RNA among participants in the facility-based arm. In the community-based arm, 37 (1.2%) had positive HCV RDT including 32 (1.1%) with detectable HCV RNA. Treatment uptake concerned 36 participants (out of 39 with positive HCV RDT) and 30 (out of 32) in the facility-based and community-based arms, respectively. The odds of combined testing uptake in the community-based strategy were 2.18 (95% CI [1.28–3.73], p = 0.004) times higher than in the facility-based strategy.</div></div><div><h3>Interpretation</h3><div>Combined testing uptake (HCV RDT or HCV RDT/RNA) was higher for the community-based strategy than for the facility-based strategy. The involvement of community health workers improved first contact with HCV services and uptake. Integrating this trial's community-based screening strategy into the national Cambodian HCV program could improve its effectiveness as part of the country's broader goal of eliminating HCV by 2030.</div></div><div><h3>Funding</h3><div>This study was supported by the <span>ANRS</span> MIE (ANRS 12384).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101703"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145268915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study Lancet Reg Health West Pac (2023) 38: 100846 一项比较自身抗体诊断方法在重症肌无力中的准确性的多中心、前瞻性、双盲研究的勘误表:SCREAM研究Lancet Reg Health West Pac (2023) 38: 100846
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101665
Zhiguo Li , Chao Zhang , Ting Chang , Xinghu Zhang , Huan Yang , Feng Gao , Jinzhou Feng , Hongbo Liu , Sheng Chen , Lihua Wang , Chunsheng Yang , Huining Li , Yuesong Pan , Jacqueline Palace , Fu-Dong Shi
{"title":"Corrigendum to A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study Lancet Reg Health West Pac (2023) 38: 100846","authors":"Zhiguo Li ,&nbsp;Chao Zhang ,&nbsp;Ting Chang ,&nbsp;Xinghu Zhang ,&nbsp;Huan Yang ,&nbsp;Feng Gao ,&nbsp;Jinzhou Feng ,&nbsp;Hongbo Liu ,&nbsp;Sheng Chen ,&nbsp;Lihua Wang ,&nbsp;Chunsheng Yang ,&nbsp;Huining Li ,&nbsp;Yuesong Pan ,&nbsp;Jacqueline Palace ,&nbsp;Fu-Dong Shi","doi":"10.1016/j.lanwpc.2025.101665","DOIUrl":"10.1016/j.lanwpc.2025.101665","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101665"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145222433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of cancer associated with residential exposure to asbestos insulation: updated evidence 与住宅暴露于石棉绝缘材料相关的癌症风险:最新证据
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101699
Hsei Di Law , Mark Clements , Nina Lazarevic , Kayla Smurthwaite , Susan Trevenar , Leah Newman , Elizabeth Chalker , Martyn D. Kirk , Rosemary J. Korda
{"title":"Risk of cancer associated with residential exposure to asbestos insulation: updated evidence","authors":"Hsei Di Law ,&nbsp;Mark Clements ,&nbsp;Nina Lazarevic ,&nbsp;Kayla Smurthwaite ,&nbsp;Susan Trevenar ,&nbsp;Leah Newman ,&nbsp;Elizabeth Chalker ,&nbsp;Martyn D. Kirk ,&nbsp;Rosemary J. Korda","doi":"10.1016/j.lanwpc.2025.101699","DOIUrl":"10.1016/j.lanwpc.2025.101699","url":null,"abstract":"","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101699"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145269493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changing patterns of education, marriage and fertility in Chinese adolescents: a systematic synthesis of national and subnational population data from 1990 to 2020 中国青少年教育、婚姻和生育模式的变化:1990 - 2020年全国和地方人口数据的系统综合
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101706
Dongmei Luo , Xiaojin Yan , Tianyu Huang , Jiajia Dang , Shan Cai , Yi Song , Susan M. Sawyer

Background

Secondary education, and early marriage and childbirth are major determinants of health and wellbeing. We aimed to describe the long-term trends and inequalities of these three indicators in Chinese adolescents over three decades of dramatic social and economic change.

Methods

Using data from Chinese population censuses and 1% population sample surveys from 1990 to 2020 (the most recent survey), we calculated the senior secondary school participation rate in 20–24-year-olds, the ever-married rate in 15–19-year-olds, and the age-specific fertility rate in 15–19 year-old females, by urban-rural location and province.

Findings

In urban areas, the secondary school participation rate substantially increased, from 34.7% in 1990 to 82.4% in 2020 for females and from 38.7% to 77.0% for males. The participation rate in rural areas also greatly increased, from 5.0% in 1990 to 55.7% in 2020 for females and from 9.1% to 51.0% for males, but remained markedly lower than in urban areas at all time points. The ever-married rate decreased dramatically from 1990 to 2005, rebounded between 2005 and 2015, and then dropped so that the rate in 2020 was at a level comparable to that in 2005 (0.7% [95% CI 0.7–0.7] for urban females, 2.2% [2.1–2.2] for rural females, 0.2% [0.2–0.2] for urban males, and 0.5% [0.5–0.5] for rural males). In urban areas, the fertility rate decreased from 10.1 per 1000 in 1990 to 2.4 (2.3–2.4) per 1000 in 2000, but then largely stabilised between 2000 and 2020. For rural adolescents, the fertility rate also decreased dramatically from 25.9 per 1000 in 1990 to 8.5 (8.2–8.8) per 1000 in 2005. The fertility rate rebounded to 15.4 (14.9–15.9) per 1000 in 2015 and decreased to 12.5 (12.3–12.7) in 2020 in rural areas. These three indicators greatly varied by province in 2020, with more negative patterns in western provinces.

Interpretation

China has seen dramatic changes in adolescent education, and early marriage and fertility over the past three decades but large inequities persist between urban-rural areas and by province. Government investments are needed to promote education in rural areas and western regions to promote more equitable health, development and wellbeing in Chinese adolescents.

Funding

National Nature Science Foundation of China.
中等教育、早婚和早育是健康和福祉的主要决定因素。我们的目的是描述这三个指标的长期趋势和不平等的中国青少年在三十年的戏剧性的社会和经济变化。方法利用1990 - 2020年中国人口普查数据和1%人口抽样调查数据,按城乡、省份分别计算20 - 24岁青年高中入学率、15-19岁青年未婚率和15-19岁青年女性年龄分生育率。在城市地区,中学入学率大幅提高,女性中学入学率从1990年的34.7%提高到2020年的82.4%,男性中学入学率从38.7%提高到77.0%。农村地区的参与率也大幅提高,女性参与率从1990年的5.0%提高到2020年的55.7%,男性参与率从9.1%提高到51.0%,但在所有时间点都明显低于城市地区。1990年至2005年,中国的未婚率急剧下降,2005年至2015年出现反弹,随后下降,到2020年的水平与2005年相当(城市女性为0.7% [95% CI 0.7-0.7],农村女性为2.2%[2.1-2.2],城市男性为0.2%[0.2-0.2],农村男性为0.5%[0.5-0.5])。在城市地区,生育率从1990年的千分之10.1下降到2000年的千分之2.4(2.3-2.4),但随后在2000年至2020年期间基本稳定下来。农村青少年的生育率也从1990年的25.9‰急剧下降到2005年的8.5‰(8.2-8.8‰)。2015年农村生育率回升至15.4‰(14.9-15.9),2020年下降至12.5‰(12.3-12.7)。2020年各省间这三项指标差异较大,西部省份负向趋势更为明显。在过去的三十年里,中国在青少年教育、早婚和生育率方面发生了巨大的变化,但城乡之间和各省之间仍然存在巨大的不平等。需要政府投资来促进农村地区和西部地区的教育,以促进中国青少年更公平的健康、发展和福祉。国家自然科学基金。
{"title":"Changing patterns of education, marriage and fertility in Chinese adolescents: a systematic synthesis of national and subnational population data from 1990 to 2020","authors":"Dongmei Luo ,&nbsp;Xiaojin Yan ,&nbsp;Tianyu Huang ,&nbsp;Jiajia Dang ,&nbsp;Shan Cai ,&nbsp;Yi Song ,&nbsp;Susan M. Sawyer","doi":"10.1016/j.lanwpc.2025.101706","DOIUrl":"10.1016/j.lanwpc.2025.101706","url":null,"abstract":"<div><h3>Background</h3><div>Secondary education, and early marriage and childbirth are major determinants of health and wellbeing. We aimed to describe the long-term trends and inequalities of these three indicators in Chinese adolescents over three decades of dramatic social and economic change.</div></div><div><h3>Methods</h3><div>Using data from Chinese population censuses and 1% population sample surveys from 1990 to 2020 (the most recent survey), we calculated the senior secondary school participation rate in 20–24-year-olds, the ever-married rate in 15–19-year-olds, and the age-specific fertility rate in 15–19 year-old females, by urban-rural location and province.</div></div><div><h3>Findings</h3><div>In urban areas, the secondary school participation rate substantially increased, from 34.7% in 1990 to 82.4% in 2020 for females and from 38.7% to 77.0% for males. The participation rate in rural areas also greatly increased, from 5.0% in 1990 to 55.7% in 2020 for females and from 9.1% to 51.0% for males, but remained markedly lower than in urban areas at all time points. The ever-married rate decreased dramatically from 1990 to 2005, rebounded between 2005 and 2015, and then dropped so that the rate in 2020 was at a level comparable to that in 2005 (0.7% [95% CI 0.7–0.7] for urban females, 2.2% [2.1–2.2] for rural females, 0.2% [0.2–0.2] for urban males, and 0.5% [0.5–0.5] for rural males). In urban areas, the fertility rate decreased from 10.1 per 1000 in 1990 to 2.4 (2.3–2.4) per 1000 in 2000, but then largely stabilised between 2000 and 2020. For rural adolescents, the fertility rate also decreased dramatically from 25.9 per 1000 in 1990 to 8.5 (8.2–8.8) per 1000 in 2005. The fertility rate rebounded to 15.4 (14.9–15.9) per 1000 in 2015 and decreased to 12.5 (12.3–12.7) in 2020 in rural areas. These three indicators greatly varied by province in 2020, with more negative patterns in western provinces.</div></div><div><h3>Interpretation</h3><div>China has seen dramatic changes in adolescent education, and early marriage and fertility over the past three decades but large inequities persist between urban-rural areas and by province. Government investments are needed to promote education in rural areas and western regions to promote more equitable health, development and wellbeing in Chinese adolescents.</div></div><div><h3>Funding</h3><div><span>National Nature Science Foundation of China</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101706"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145363090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-life NO2 exposure and sleep disturbances in preschool children: a study from 551 cities across China 学龄前儿童早期二氧化氮暴露与睡眠障碍:来自中国551个城市的研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101701
Yuanxin Lin , Yang Shen , Xia Meng , Haidong Kan , Jing Cai , Jing Hua

Background

Ambient nitrogen dioxide (NO2) has been linked to sleep disturbances in adults, yet its impact on pediatric populations remains understudied.

Methods

A total of 112,471 children aged 3–7 years from the Chinese National Cohort of Motor Development were enrolled. Sleep quality was assessed using the Children's Sleep Habits Questionnaire (CSHQ), while NO2 exposure at home addresses was estimated through a satellite-based spatiotemporal model. Linear mixed-effect models and generalized estimating equations were employed to quantify the associations of NO2 exposure with CSHQ scores and sleep disturbances, with the adjustment for demographics, meteorological parameters.

Findings

Early-life NO2 exposure was associated with higher CSHQ scores and increased risk of sleep disturbances. Per 10 μg/m3 increase in NO2 exposure during 0–3 years and the entire pregnancy was associated with 0.23 (95% confidence interval [CI]: 0.12–0.33) and 0.18 (95% CI: 0.09–0.27) increases in CSHQ score, respectively, indicating poorer sleep quality. A 10 μg/m3 increase in NO2 exposure from ages 0–3 years and during the pregnancy was associated with a 1.1% (relative risk [RR] = 1.011, 95% CI: 1.004–1.018) and 1.0% (RR = 1.010, 95% CI: 1.004–1.016) higher risk of sleep disturbances, respectively. Higher NO2 exposure was linked to greater likelihood of sleep onset delay, sleep-disordered breathing, and daytime sleepiness. The association appeared more pronounced among children exclusively breastfed <6 months (RR = 1.018, 95% CI: 1.001–1.034) compared with those breastfed ≥6 months (RR = 1.009, 95% CI: 1.001–1.018).

Interpretation

Early-life exposure to NO2 is associated with poorer sleep quality in preschool-aged children, highlighting the importance of mitigating air pollution exposure during critical developmental periods to support healthy sleep and child development.

Funding

Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China, and Shanghai Municipal Health Commission.
环境中的二氧化氮(NO2)与成人睡眠障碍有关,但其对儿科人群的影响仍未得到充分研究。方法从中国国家运动发展队列中招募了112,471名3-7岁的儿童。使用儿童睡眠习惯问卷(CSHQ)评估睡眠质量,而通过基于卫星的时空模型估计家庭住址的二氧化氮暴露。采用线性混合效应模型和广义估计方程,在调整人口统计、气象参数的情况下,量化二氧化氮暴露与CSHQ评分和睡眠障碍的关系。研究发现,幼年接触二氧化氮与较高的CSHQ评分和睡眠障碍风险增加有关。在0-3年和整个妊娠期间,NO2暴露每增加10 μg/m3, CSHQ评分分别增加0.23(95%可信区间[CI]: 0.12-0.33)和0.18 (95% CI: 0.09-0.27),表明睡眠质量较差。0-3岁和孕期NO2暴露量每增加10 μg/m3,睡眠障碍风险分别增加1.1%(相对危险度[RR] = 1.011, 95% CI: 1.004-1.018)和1.0%(相对危险度[RR] = 1.010, 95% CI: 1.004-1.016)。较高的二氧化氮暴露与睡眠开始延迟、睡眠呼吸障碍和白天嗜睡的可能性较大有关。与母乳喂养≥6个月的儿童(RR = 1.009, 95% CI: 1.001-1.018)相比,纯母乳喂养≥6个月的儿童(RR = 1.009, 95% CI: 1.001-1.018)的相关性更为明显。生命早期接触二氧化氮与学龄前儿童较差的睡眠质量有关,这突出了在关键发育时期减少空气污染对支持健康睡眠和儿童发育的重要性。中华人民共和国科学技术部、国家自然科学基金、上海市卫生健康委员会资助。
{"title":"Early-life NO2 exposure and sleep disturbances in preschool children: a study from 551 cities across China","authors":"Yuanxin Lin ,&nbsp;Yang Shen ,&nbsp;Xia Meng ,&nbsp;Haidong Kan ,&nbsp;Jing Cai ,&nbsp;Jing Hua","doi":"10.1016/j.lanwpc.2025.101701","DOIUrl":"10.1016/j.lanwpc.2025.101701","url":null,"abstract":"<div><h3>Background</h3><div>Ambient nitrogen dioxide (NO<sub>2</sub>) has been linked to sleep disturbances in adults, yet its impact on pediatric populations remains understudied.</div></div><div><h3>Methods</h3><div>A total of 112,471 children aged 3–7 years from the Chinese National Cohort of Motor Development were enrolled. Sleep quality was assessed using the Children's Sleep Habits Questionnaire (CSHQ), while NO<sub>2</sub> exposure at home addresses was estimated through a satellite-based spatiotemporal model. Linear mixed-effect models and generalized estimating equations were employed to quantify the associations of NO<sub>2</sub> exposure with CSHQ scores and sleep disturbances, with the adjustment for demographics, meteorological parameters.</div></div><div><h3>Findings</h3><div>Early-life NO<sub>2</sub> exposure was associated with higher CSHQ scores and increased risk of sleep disturbances. Per 10 μg/m<sup>3</sup> increase in NO<sub>2</sub> exposure during 0–3 years and the entire pregnancy was associated with 0.23 (95% confidence interval [CI]: 0.12–0.33) and 0.18 (95% CI: 0.09–0.27) increases in CSHQ score, respectively, indicating poorer sleep quality. A 10 μg/m<sup>3</sup> increase in NO<sub>2</sub> exposure from ages 0–3 years and during the pregnancy was associated with a 1.1% (relative risk [RR] = 1.011, 95% CI: 1.004–1.018) and 1.0% (RR = 1.010, 95% CI: 1.004–1.016) higher risk of sleep disturbances, respectively. Higher NO<sub>2</sub> exposure was linked to greater likelihood of sleep onset delay, sleep-disordered breathing, and daytime sleepiness. The association appeared more pronounced among children exclusively breastfed &lt;6 months (RR = 1.018, 95% CI: 1.001–1.034) compared with those breastfed ≥6 months (RR = 1.009, 95% CI: 1.001–1.018).</div></div><div><h3>Interpretation</h3><div>Early-life exposure to NO<sub>2</sub> is associated with poorer sleep quality in preschool-aged children, highlighting the importance of mitigating air pollution exposure during critical developmental periods to support healthy sleep and child development.</div></div><div><h3>Funding</h3><div><span>Ministry of Science and Technology of the People's Republic of China</span>, <span>National Natural Science Foundation of China</span>, and <span>Shanghai Municipal Health Commission</span>.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101701"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145269350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large language models and global health equity: a roadmap for equitable adoption in LMICs 大型语言模型与全球卫生公平:中低收入国家公平采用的路线图
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101707
Haichao Chen , Dian Zeng , Yiming Qin , Zeyue Fan , Faye Ng Yu Ci , David C. Klonoff , John S. Ji , Shuyang Zhang , Kwesi Nyan Amissah-Arthur , Michelle María Jiménez de Tavárez , Saleha Masood , Phuoc Van Le , Pearse A. Keane , Bin Sheng , Tien Yin Wong , Yih Chung Tham
Large language models (LLMs) have been proposed to address global health inequity by providing accessible and high-quality health care, particularly in low- and middle-income countries (LMICs). However, despite the early enthusiasm following the release of GPT, development and deployment of LLMs have remained heavily concentrated in high-income countries (HIC), raising concerns that such technology may worsen existing health disparities instead of alleviating them. The most recent LLMs, which include features such as lower cost, and open-source framework, show promise in rebalancing LLMs' benefits worldwide. In this viewpoint, we examine the current challenges and imbalance in LLM deployment across global regions, identify the key barriers to adoption in LMICs, assess current LLMs' advances and the new opportunities they bring to global health equity. We also propose a five-dimensional roadmap—focusing on people, products, platforms, processes, and policies—to advance LLMs' equitable adoption in LMIC and improve inclusive progress in global health.

Funding

National Key R&D Program (Grant No: 2022YFC2502800); National Natural Science Fund of China (Grant No: 82388101); Beijing Natural Science Foundation (Grant No: IS23096).
已经提出了大型语言模型(LLMs),通过提供可获得的高质量卫生保健来解决全球卫生不平等问题,特别是在低收入和中等收入国家。然而,尽管在GPT发布后出现了早期的热情,但llm的开发和部署仍然主要集中在高收入国家(HIC),这引起了人们的担忧,即这种技术可能会加剧而不是缓解现有的健康差距。最新的法学硕士,包括更低的成本和开源框架等特点,显示出在全球范围内重新平衡法学硕士利益的希望。在这一观点下,我们研究了全球各地区法学硕士部署的当前挑战和不平衡,确定了中低收入国家采用法学硕士的主要障碍,评估了当前法学硕士的进展及其为全球卫生公平带来的新机遇。我们还提出了一个以人、产品、平台、流程和政策为重点的五维路线图,以促进法学硕士在中低收入国家的公平采用,并促进全球卫生领域的包容性进展。国家重点研发计划(批准号:2022YFC2502800);国家自然科学基金(批准号:82388101);北京市自然科学基金(资助号:IS23096)。
{"title":"Large language models and global health equity: a roadmap for equitable adoption in LMICs","authors":"Haichao Chen ,&nbsp;Dian Zeng ,&nbsp;Yiming Qin ,&nbsp;Zeyue Fan ,&nbsp;Faye Ng Yu Ci ,&nbsp;David C. Klonoff ,&nbsp;John S. Ji ,&nbsp;Shuyang Zhang ,&nbsp;Kwesi Nyan Amissah-Arthur ,&nbsp;Michelle María Jiménez de Tavárez ,&nbsp;Saleha Masood ,&nbsp;Phuoc Van Le ,&nbsp;Pearse A. Keane ,&nbsp;Bin Sheng ,&nbsp;Tien Yin Wong ,&nbsp;Yih Chung Tham","doi":"10.1016/j.lanwpc.2025.101707","DOIUrl":"10.1016/j.lanwpc.2025.101707","url":null,"abstract":"<div><div>Large language models (LLMs) have been proposed to address global health inequity by providing accessible and high-quality health care, particularly in low- and middle-income countries (LMICs). However, despite the early enthusiasm following the release of GPT, development and deployment of LLMs have remained heavily concentrated in high-income countries (HIC), raising concerns that such technology may worsen existing health disparities instead of alleviating them. The most recent LLMs, which include features such as lower cost, and open-source framework, show promise in rebalancing LLMs' benefits worldwide. In this viewpoint, we examine the current challenges and imbalance in LLM deployment across global regions, identify the key barriers to adoption in LMICs, assess current LLMs' advances and the new opportunities they bring to global health equity. We also propose a five-dimensional roadmap—focusing on people, products, platforms, processes, and policies—to advance LLMs' equitable adoption in LMIC and improve inclusive progress in global health.</div></div><div><h3>Funding</h3><div><span>National Key R&amp;D Program</span> (Grant No: <span><span>2022YFC2502800</span></span>); <span>National Natural Science Fund of China</span> (Grant No: <span><span>82388101</span></span>); <span>Beijing Natural Science Foundation</span> (Grant No: <span><span>IS23096</span></span>).</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101707"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145325925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidrug-resistant tuberculosis household contact screening and management by community healthcare workers in Mongolia: a prospective implementation study 蒙古社区卫生保健工作者对耐多药结核病家庭接触者的筛查和管理:一项前瞻性实施研究
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-10-01 DOI: 10.1016/j.lanwpc.2025.101704
Bazarragchaa Tsogt , Tsegmed Sambuu , Yanjindulam Purevsuren , Sergelen Munkhbaatar , Purevsuren Batsuren , Oyun-Erdene Khandaa , Narantsetseg Doyod , Nasanjargal Byambaa , Norovrenchin Tsogtgerel , Gregory J. Fox , Stephen M. Graham

Background

Mongolia is a high burden country for multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB). The implementation of systematic household TB contact investigation has been very limited despite policy recommendations. We implemented a community-based approach to MDR/RR-TB contact screening and management.

Methods

We conducted a prospective implementation study in the nine districts of Ulaanbaatar and 10 other provinces. Community health workers (CHWs) were trained to identify and screen household contacts of patients with confirmed pulmonary MDR/RR-TB. Initial screening included symptom assessment for all with chest radiography for adult contacts or tuberculin skin test (TST) for child or young adolescent contacts (<15 years). Follow-up visits to households were conducted quarterly for 12 months. Six months of daily levofloxacin (6Lfx) was offered to eligible contacts, i.e. <15 years, TST-positive and without disease.

Findings

Of 99 people with pulmonary MDR/RR-TB, 349 household contacts were identified and 347 (99.4%) were screened by CHWs at initial home-based visit. Contact screening coverage remained high (>98%) for each quarterly visit up to 12 months of follow-up. TB was diagnosed in 17 contacts (4.9%); ten from initial screen, seven from follow-up screen and 12 (71%) were children or adolescents. Four contacts were diagnosed with bacteriologically confirmed MDR/RR-TB and two died. 6Lfx was initiated in 15 (43%) of 35 eligible contacts who all completed therapy without interruption.

Interpretation

A decentralized model for the screening and management of MDR/RR-TB contacts implemented by trained CHWs has wider potential for increasing TB detection and prevention in Mongolia and the region.

Funding

John Burge Trust and National Health and Medical Research Council, Australia.
蒙古是耐多药或利福平结核病(MDR/RR-TB)的高负担国家。尽管有政策建议,但系统的家庭结核接触调查的实施非常有限。我们实施了以社区为基础的MDR/RR-TB接触者筛查和管理方法。方法在乌兰巴托市9个区和其他10个省进行前瞻性实施研究。对社区卫生工作者进行了培训,以确定和筛查肺部耐多药/耐药结核病确诊患者的家庭接触者。初步筛查包括对所有接触者进行症状评估,对成人进行胸片检查,对儿童或青少年(15岁)进行结核菌素皮肤试验(TST)。每季对住户进行随访,为期12个月。为符合条件的接触者提供6个月的每日左氧氟沙星(6Lfx),即15岁,tst阳性且无疾病。结果99例肺部MDR/RR-TB患者中,有349例家庭接触者被确定,347例(99.4%)在最初的家庭访问中由卫生保健员筛查。随访12个月期间,每季度就诊的接触者筛查覆盖率仍然很高(98%)。17名接触者(4.9%)被诊断患有结核病;10例来自初次筛查,7例来自随访筛查,12例(71%)为儿童或青少年。4名接触者被诊断为细菌学上确诊的耐多药/耐药结核,2人死亡。35名符合条件的接触者中有15名(43%)开始使用lfx,他们全部完成了治疗,没有中断。由训练有素的卫生保健员实施的MDR/RR-TB接触者筛查和管理的分散模式在蒙古和该地区具有更大的潜力,可以增加结核病的发现和预防。资助john Burge信托基金和澳大利亚国家健康和医学研究委员会。
{"title":"Multidrug-resistant tuberculosis household contact screening and management by community healthcare workers in Mongolia: a prospective implementation study","authors":"Bazarragchaa Tsogt ,&nbsp;Tsegmed Sambuu ,&nbsp;Yanjindulam Purevsuren ,&nbsp;Sergelen Munkhbaatar ,&nbsp;Purevsuren Batsuren ,&nbsp;Oyun-Erdene Khandaa ,&nbsp;Narantsetseg Doyod ,&nbsp;Nasanjargal Byambaa ,&nbsp;Norovrenchin Tsogtgerel ,&nbsp;Gregory J. Fox ,&nbsp;Stephen M. Graham","doi":"10.1016/j.lanwpc.2025.101704","DOIUrl":"10.1016/j.lanwpc.2025.101704","url":null,"abstract":"<div><h3>Background</h3><div>Mongolia is a high burden country for multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB). The implementation of systematic household TB contact investigation has been very limited despite policy recommendations. We implemented a community-based approach to MDR/RR-TB contact screening and management.</div></div><div><h3>Methods</h3><div>We conducted a prospective implementation study in the nine districts of Ulaanbaatar and 10 other provinces. Community health workers (CHWs) were trained to identify and screen household contacts of patients with confirmed pulmonary MDR/RR-TB. Initial screening included symptom assessment for all with chest radiography for adult contacts or tuberculin skin test (TST) for child or young adolescent contacts (&lt;15 years). Follow-up visits to households were conducted quarterly for 12 months. Six months of daily levofloxacin (6Lfx) was offered to eligible contacts, i.e. &lt;15 years, TST-positive and without disease.</div></div><div><h3>Findings</h3><div>Of 99 people with pulmonary MDR/RR-TB, 349 household contacts were identified and 347 (99.4%) were screened by CHWs at initial home-based visit. Contact screening coverage remained high (&gt;98%) for each quarterly visit up to 12 months of follow-up. TB was diagnosed in 17 contacts (4.9%); ten from initial screen, seven from follow-up screen and 12 (71%) were children or adolescents. Four contacts were diagnosed with bacteriologically confirmed MDR/RR-TB and two died. 6Lfx was initiated in 15 (43%) of 35 eligible contacts who all completed therapy without interruption.</div></div><div><h3>Interpretation</h3><div>A decentralized model for the screening and management of MDR/RR-TB contacts implemented by trained CHWs has wider potential for increasing TB detection and prevention in Mongolia and the region.</div></div><div><h3>Funding</h3><div><span>John Burge Trust</span> and <span>National Health and Medical Research Council</span>, Australia.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101704"},"PeriodicalIF":8.1,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145268917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial 新辅助奇达胺联合化疗治疗激素受体阳性、人表皮生长因子受体2阴性乳腺癌(MUKDEN 05):一项多中心、单臂、2期试验
IF 8.1 1区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2025-09-27 DOI: 10.1016/j.lanwpc.2025.101700
Jinqi Xue , Huilian Shan , Fang Qiu , Nan Niu , Guanglei Chen , Qianshi Xu , Xi Gu , Fei Xing , Yongqing Xu , Xinyu Zheng , Guijin He , Hong Xu , Hao Zhang , Dong Song , Ye Han , Meiyue Tang , Shuo Cao , Yang Song , Ran Zheng , Yafei Zhao , Caigang Liu

Background

Existing neoadjuvant therapies for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2−) breast cancer have not achieved optimal clinical outcomes, thus prompting the investigation of novel treatment strategies. Given the emerging significance of HDAC inhibitors in the management of advanced breast cancer, this study investigated the efficacy and safety of chidamide plus chemotherapy as neoadjuvant therapy for patients with HR+/HER2− breast cancer.

Methods

This single arm, open-label, multicentre, phase 2 trial was conducted at three hospitals in China. Patients aged 18–75 years who had treatment-naïve, stage II–III HR+/HER2− breast cancer with an Eastern Cooperative Oncology Group performance status of 0–1 were enrolled. Patients received oral chidamide at a dose of 20 mg on days 1, 4, 8, and 11 of each 21-day cycle. The chemotherapy regimen consisted of four cycles of epirubicin (90 mg/m2) and cyclophosphamide (600 mg/m2) administered every three weeks, followed by four cycles of docetaxel (100 mg/m2) administered every three weeks. The primary endpoint was the rate of residual cancer burden (RCB) 0–I. This study is registered with ClinicalTrials.gov, NCT05400993.

Findings

Between May 23, 2022 and July 6, 2023, a total of 54 female patients (median age: 50 years [range, 26–75]) were recruited. The RCB 0–I rate was 35.2% (19 of 54, 95% confidence interval [CI], 22.7%–49.4%). The most frequent grade 3 or 4 adverse events were decreased neutrophil count (70%) and decreased white blood cell (67%). No treatment-related deaths occurred.

Interpretation

The combination of chidamide and chemotherapy shows the potential to be an alternative neoadjuvant therapy option for patients with HR+/HER2− breast cancer.

Funding

Shenyang Municipal Science and Technology Program (Grant No. 22-321-32-18), Shenzhen Chipscreen Biosciences Co., Ltd.
现有的激素受体阳性、人表皮生长因子受体2阴性(HR+/HER2−)乳腺癌的新辅助治疗尚未取得最佳临床结果,因此需要研究新的治疗策略。鉴于HDAC抑制剂在晚期乳腺癌治疗中的新意义,本研究探讨了奇达胺联合化疗作为HR+/HER2−乳腺癌患者新辅助治疗的有效性和安全性。方法该单臂、开放标签、多中心、2期临床试验在中国3家医院进行。纳入年龄18-75岁的treatment-naïve II-III期HR+/HER2 -乳腺癌患者,东部肿瘤合作组评分为0-1。患者在每个21天周期的第1、4、8和11天口服剂量为20mg的奇达胺。化疗方案包括表柔比星(90 mg/m2)和环磷酰胺(600 mg/m2)每3周给药4个周期,然后每3周给药4个周期多西紫杉醇(100 mg/m2)。主要终点为残余癌症负担率(RCB) 0 - 1。本研究已在ClinicalTrials.gov注册,编号NCT05400993。研究结果:在2022年5月23日至2023年7月6日期间,共招募了54名女性患者(中位年龄:50岁[范围,26-75岁])。RCB 0-I率为35.2%(19 / 54,95%可信区间[CI], 22.7%-49.4%)。最常见的3级或4级不良事件是中性粒细胞计数减少(70%)和白细胞减少(67%)。无治疗相关死亡发生。解释:奇达胺联合化疗有可能成为HR+/HER2−乳腺癌患者的新辅助治疗选择。沈阳市科技计划(批准号:22-321-32-18),深圳晶屏生物科技有限公司
{"title":"Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial","authors":"Jinqi Xue ,&nbsp;Huilian Shan ,&nbsp;Fang Qiu ,&nbsp;Nan Niu ,&nbsp;Guanglei Chen ,&nbsp;Qianshi Xu ,&nbsp;Xi Gu ,&nbsp;Fei Xing ,&nbsp;Yongqing Xu ,&nbsp;Xinyu Zheng ,&nbsp;Guijin He ,&nbsp;Hong Xu ,&nbsp;Hao Zhang ,&nbsp;Dong Song ,&nbsp;Ye Han ,&nbsp;Meiyue Tang ,&nbsp;Shuo Cao ,&nbsp;Yang Song ,&nbsp;Ran Zheng ,&nbsp;Yafei Zhao ,&nbsp;Caigang Liu","doi":"10.1016/j.lanwpc.2025.101700","DOIUrl":"10.1016/j.lanwpc.2025.101700","url":null,"abstract":"<div><h3>Background</h3><div>Existing neoadjuvant therapies for hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2−) breast cancer have not achieved optimal clinical outcomes, thus prompting the investigation of novel treatment strategies. Given the emerging significance of HDAC inhibitors in the management of advanced breast cancer, this study investigated the efficacy and safety of chidamide plus chemotherapy as neoadjuvant therapy for patients with HR+/HER2− breast cancer.</div></div><div><h3>Methods</h3><div>This single arm, open-label, multicentre, phase 2 trial was conducted at three hospitals in China. Patients aged 18–75 years who had treatment-naïve, stage II–III HR+/HER2− breast cancer with an Eastern Cooperative Oncology Group performance status of 0–1 were enrolled. Patients received oral chidamide at a dose of 20 mg on days 1, 4, 8, and 11 of each 21-day cycle. The chemotherapy regimen consisted of four cycles of epirubicin (90 mg/m<sup>2</sup>) and cyclophosphamide (600 mg/m<sup>2</sup>) administered every three weeks, followed by four cycles of docetaxel (100 mg/m<sup>2</sup>) administered every three weeks. The primary endpoint was the rate of residual cancer burden (RCB) 0–I. This study is registered with <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span>, <span><span>NCT05400993</span><svg><path></path></svg></span>.</div></div><div><h3>Findings</h3><div>Between May 23, 2022 and July 6, 2023, a total of 54 female patients (median age: 50 years [range, 26–75]) were recruited. The RCB 0–I rate was 35.2% (19 of 54, 95% confidence interval [CI], 22.7%–49.4%). The most frequent grade 3 or 4 adverse events were decreased neutrophil count (70%) and decreased white blood cell (67%). No treatment-related deaths occurred.</div></div><div><h3>Interpretation</h3><div>The combination of chidamide and chemotherapy shows the potential to be an alternative neoadjuvant therapy option for patients with HR+/HER2− breast cancer.</div></div><div><h3>Funding</h3><div><span>Shenyang Municipal Science and Technology Program</span> (Grant No. <span><span>22-321-32-18</span></span>), Shenzhen Chipscreen Biosciences Co., Ltd.</div></div>","PeriodicalId":22792,"journal":{"name":"The Lancet Regional Health: Western Pacific","volume":"63 ","pages":"Article 101700"},"PeriodicalIF":8.1,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145159943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Lancet Regional Health: Western Pacific
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1